期刊文献+

心房颤动120例临床分析

心房颤动120例临床分析
下载PDF
导出
摘要 目的:探讨心房颤动(房颤)患者的病因分布特点及治疗方法。方法:对2006~2011年收治120例合并房颤的患者进行病因及治疗情况的回顾性分析。结果:房颤病因以冠心病居首,高血压次之。19例阵发性房颤用胺碘酮或普罗帕酮复律并维持窦性心律安全有效。持续性房颤33例,永久性房颤心68例,心室率控制均较满意。结论:房颤的主要病因为冠心病、高血压,关注房颤的病因,对预防和治疗具有重要意义。 Objective:To understand the pa- thogeny of and treatment for atrial fibrillation(AF). Methods : The pathogeny type, artery embolization complications, treatment and prognosis of 120 hospitalized patients with atrial fibrillation from 2006 to 2011 were analyzed retrospectively. Results : Coronary heart disease ranked the hrst,followed by hypertension in pathogeny. Amiodarone and Propafenone were safe and effective for treatment of cardioversion of paroxysmal atrial fibrillation and maintenance of sinus rhythm. Conclusions: Coronary disease and hypertension are the major causes of atrial fibrillation. Analysis of the causes of atrial fibrillation is of great value for the prevention and treatment of the disease.
作者 林勇军 袁帅
出处 《中国社区医师(医学专业)》 2011年第24期64-65,共2页
关键词 心房颤动 冠心病 高血压 Atrial fibrillation Coronary disease Hypenension
  • 相关文献

参考文献4

二级参考文献31

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1399
  • 2张学义,张薇,郑兆通,钟明,黎莉,张运.非瓣膜性心房颤动并发缺血性脑卒中的防治[J].中华急诊医学杂志,2004,13(9):592-594. 被引量:21
  • 3SPORTIF Ⅲ Investigators. Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF Ⅲ): randomized controlled trial [J] .Lancet, 2003, 362(9397):1691.
  • 4Halperin JL. Efficacy and safety study of oral direct thromnin inhibitor ximelagatran compared with dose-adjusted warfarin in the prevention of stroke and systemic embolic events in patients with atrial fibrillation:SPORTIF V [C] . American Heart Associat
  • 5Kalta L, Yu G, Perez I, et al. Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness [J] .BMJ, 2000, 320(7244):1236.
  • 6Economides Munoz C, Singh BN. Antithrombotic Therapies for stroke prevention fibrillation [J] . Minerva Cardioangiol, 2004, 52(2):125.
  • 7Ferro JM. Atrial fibrillation and cardioembolic stroke [J] . Minerva Cardiangiol, 2004, 52(2):111.
  • 8Anderson M, Kirk M. Anticoagulation in atrial fibrillation [J] . MedHealthR. I. 2004, 87(4):98.
  • 9Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage: Facts and hypotheses [J] . Stroke, 1995, 26(8): 1471.
  • 10Lip GYH, Hart RG, Conway DSG. Antithrombotic therapy for atrial fibrillation [J] . BMJ, 2002, 325(7371):1022.

共引文献201

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部